PMV Pharmaceuticals, Inc. (PMVP)
Nasdaq: PMVP · CIK 0001699382 · United States
Every official PMV Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open PMVP filings
PMV Pharmaceuticals, Inc. documents
- PMV Pharmaceuticals, Inc. 10-K 2026PMVP 10-K 2026: annual report for fiscal 2026
- PMV Pharmaceuticals, Inc. 10-K 2025PMVP 10-K 2025: annual report for fiscal 2025
- PMV Pharmaceuticals, Inc. 10-K 2024PMVP 10-K 2024: annual report for fiscal 2024
- PMV Pharmaceuticals, Inc. 10-K 2023PMVP 10-K 2023: annual report for fiscal 2023
- PMV Pharmaceuticals, Inc. 10-K 2022PMVP 10-K 2022: annual report for fiscal 2022
- PMV Pharmaceuticals, Inc. 10-Q 2026PMVP 10-Q 2026: quarterly report for fiscal 2026
- PMV Pharmaceuticals, Inc. 10-Q 2025PMVP 10-Q 2025: quarterly report for fiscal 2025
- PMV Pharmaceuticals, Inc. 10-Q 2024PMVP 10-Q 2024: quarterly report for fiscal 2024
- PMV Pharmaceuticals, Inc. 10-Q 2023PMVP 10-Q 2023: quarterly report for fiscal 2023
- PMV Pharmaceuticals, Inc. 10-Q 2022PMVP 10-Q 2022: quarterly report for fiscal 2022
- PMV Pharmaceuticals, Inc. 8-K 2026PMVP 8-K 2026: current report for fiscal 2026
- PMV Pharmaceuticals, Inc. 8-K 2025PMVP 8-K 2025: current report for fiscal 2025
- PMV Pharmaceuticals, Inc. 8-K 2024PMVP 8-K 2024: current report for fiscal 2024
- PMV Pharmaceuticals, Inc. 8-K 2023PMVP 8-K 2023: current report for fiscal 2023
- PMV Pharmaceuticals, Inc. 8-K 2022PMVP 8-K 2022: current report for fiscal 2022
- PMV Pharmaceuticals, Inc. DEF 14A 2026PMVP DEF 14A 2026: proxy statement for fiscal 2026
- PMV Pharmaceuticals, Inc. DEF 14A 2025PMVP DEF 14A 2025: proxy statement for fiscal 2025
- PMV Pharmaceuticals, Inc. DEF 14A 2024PMVP DEF 14A 2024: proxy statement for fiscal 2024
- PMV Pharmaceuticals, Inc. DEF 14A 2023PMVP DEF 14A 2023: proxy statement for fiscal 2023
- PMV Pharmaceuticals, Inc. DEF 14A 2022PMVP DEF 14A 2022: proxy statement for fiscal 2022
- PMV Pharmaceuticals, Inc. Form 4 2026PMVP Form 4 2026: insider trading filing for fiscal 2026
- PMV Pharmaceuticals, Inc. Form 4 2025PMVP Form 4 2025: insider trading filing for fiscal 2025
- PMV Pharmaceuticals, Inc. Form 4 2024PMVP Form 4 2024: insider trading filing for fiscal 2024
- PMV Pharmaceuticals, Inc. Form 4 2023PMVP Form 4 2023: insider trading filing for fiscal 2023
- PMV Pharmaceuticals, Inc. Form 4 2022PMVP Form 4 2022: insider trading filing for fiscal 2022
- PMV Pharmaceuticals, Inc. S-1 2026PMVP S-1 2026: registration statement for fiscal 2026
- PMV Pharmaceuticals, Inc. S-1 2025PMVP S-1 2025: registration statement for fiscal 2025
- PMV Pharmaceuticals, Inc. S-1 2024PMVP S-1 2024: registration statement for fiscal 2024
- PMV Pharmaceuticals, Inc. S-1 2023PMVP S-1 2023: registration statement for fiscal 2023
- PMV Pharmaceuticals, Inc. S-1 2022PMVP S-1 2022: registration statement for fiscal 2022
- PMV Pharmaceuticals, Inc. 13F 2026PMVP 13F 2026: institutional holdings for fiscal 2026
- PMV Pharmaceuticals, Inc. 13F 2025PMVP 13F 2025: institutional holdings for fiscal 2025
- PMV Pharmaceuticals, Inc. 13F 2024PMVP 13F 2024: institutional holdings for fiscal 2024
- PMV Pharmaceuticals, Inc. 13F 2023PMVP 13F 2023: institutional holdings for fiscal 2023
- PMV Pharmaceuticals, Inc. 13F 2022PMVP 13F 2022: institutional holdings for fiscal 2022
More companies